Investor Senrigan Capital Group Ltd
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Senrigan Capital Group Ltd . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2019-02-14 13G RVA / REVA Medical, Inc. 12,453,969
2018-02-14 13G RVA / REVA Medical, Inc. 12,453,969
2018-02-14 13G RVA / 11,972,349 12,453,969
2018-01-04 13G JASO / JA Solar Holdings Co., Ltd. 12,689,105
2017-02-14 13G/A RVA / REVA Medical, Inc. 11,972,349
2017-02-14 13G/A RVA / 11,518,308 11,972,349
2017-02-14 13G/A RVALL / Reva Medical Inc 11,518,308 11,972,349
2016-02-18 13G/A RVA / REVA Medical, Inc. 11,518,308
2016-02-18 13G/A RVA / 11,518,308
2016-02-18 13G/A RVALL / Reva Medical Inc 11,518,308